# Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer

> **NCT06855524** · PHASE2 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 34 (estimated)

## Conditions studied

- Malignant Digestive System Neoplasm
- Malignant Female Reproductive System Neoplasm

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **DIETARY_SUPPLEMENT:** Oligo-fucoidan
- **DRUG:** Placebo Administration
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT06855524
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-06
- **Primary completion:** 2027-02-28
- **Final completion:** 2027-02-28
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06855524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06855524, "Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06855524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*